{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:20:28Z","timestamp":1769599228172,"version":"3.49.0"},"reference-count":9,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,7,14]]},"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:p>A 44-year-old woman diagnosed with a HER2 positive early breast cancer, receiving neoadjuvant treatment with paclitaxel and targeted agents, trastuzumab together with pertuzumab, presented to the emergency room with gait instability and upper right limb weakness. The neurological examination was compatible with cerebellar alteration showing right dissymmetry of the finger-nose and heel-knee manoeuvre. A head CT and a brain MRI were performed and negative. The electromyography showed alterations of the pyramidal pathway and somatosensory pathway. In order to determine the cause of the cerebellar affection, a lumbar puncture was performed. The cerebrospinal fluid analysis was non-specific, but the antineuronal anti-Yo antibody was positive, being diagnosed of a paraneoplastic cerebellar degeneration (PCD). A positron emission tomography CT ruled out metastatic disease. The patient completed four cycles of antiHER2 blockade and weekly paclitaxel, achieving a complete pathological response. One year later, she maintains a complete remission but the PCD still prevails.<\/jats:p>","DOI":"10.1136\/bcr-2019-233863","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T03:20:20Z","timestamp":1598325620000},"page":"e233863","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Paraneoplastic cerebellar degeneration diagnosed by anti-Yo determination in a young woman with early breast cancer"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8492-5195","authenticated-orcid":false,"given":"Oriol","family":"Mirallas","sequence":"first","affiliation":[{"name":"Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Alejandra","family":"Rezqallah Ar\u00f3n","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Saoudi Gonzalez","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Escriv\u00e1-de-Roman\u00ed","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"key":"2025082713244860000_13.8.e233863.1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/01.CON.0000464180.89580.88","article-title":"Paraneoplastic disorders","volume":"21","author":"Lancaster","year":"2015","journal-title":"Continuum"},{"key":"2025082713244860000_13.8.e233863.2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/acn3.328","article-title":"Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review","volume":"3","author":"Venkatraman","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"2025082713244860000_13.8.e233863.3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.5.713"},{"key":"2025082713244860000_13.8.e233863.4","first-page":"1","article-title":"Anti-Yo mediated paraneoplastic cerebellar degeneration associated with pseudobulbar affect in a patient with breast cancer","volume":"2017","author":"Martin","year":"2017","journal-title":"Case Rep Oncol Med"},{"key":"2025082713244860000_13.8.e233863.5","first-page":"835","article-title":"Paraneoplastic cerebellar degeneration in a patient with pseudomyxoma peritonei and breast cancer: case report and literature review","volume":"23","author":"Ardavanis","year":"2009","journal-title":"In Vivo"},{"key":"2025082713244860000_13.8.e233863.6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/acn3.328","article-title":"Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review","volume":"3","author":"Venkatraman","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"2025082713244860000_13.8.e233863.7","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.3747\/co.25.4106","article-title":"Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review","volume":"25","author":"Le May","year":"2018","journal-title":"Curr Oncol"},{"key":"2025082713244860000_13.8.e233863.8","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos006"},{"key":"2025082713244860000_13.8.e233863.9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3816\/CBC.2006.n.016","article-title":"Subacute cerebellar degeneration as paraneoplastic syndrome: initial symptom of breast cancer with HER2 overexpression","volume":"7","author":"Sancho","year":"2006","journal-title":"Clin Breast Cancer"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-233863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T20:24:55Z","timestamp":1756326295000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-233863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":9,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,24]]},"published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1136\/bcr-2019-233863"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-233863","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}